R T Burkman

Summary

Affiliation: Baystate Medical Center
Country: USA

Publications

  1. ncbi request reprint Clinical pearls: factors affecting reported contraceptive efficacy rates in clinical studies
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Int J Fertil Womens Med 47:153-61. 2002
  2. ncbi request reprint Health economics of contraception
    R T Burkman
    Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Massachusetts, USA
    Obstet Gynecol Clin North Am 27:917-31, viii. 2000
  3. ncbi request reprint The transdermal contraceptive system
    Ronald T Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S49-53. 2004
  4. ncbi request reprint Current controversies: hormone replacement therapy and breast cancer
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Obstet Gynecol Surv 58:633-5. 2003
  5. ncbi request reprint Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study
    Ronald T Burkman
    National Cancer Institute Surveillance, Epidemiology, and End Results Registry, Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA
    Fertil Steril 79:844-51. 2003
  6. ncbi request reprint Hormone replacement therapy. Current controversies
    R T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA, USA
    Minerva Ginecol 55:107-16. 2003
  7. ncbi request reprint Safety concerns and health benefits associated with oral contraception
    Ronald Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S5-22. 2004
  8. ncbi request reprint Venous thromboembolism and oral contraceptives: current status and clinical implications
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Treat Endocrinol 1:143-7. 2002
  9. ncbi request reprint Reproductive hormones and cancer: ovarian and colon cancer
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Obstet Gynecol Clin North Am 29:527-40. 2002
  10. doi request reprint Association between efficacy and body weight or body mass index for two low-dose oral contraceptives
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Contraception 79:424-7. 2009

Detail Information

Publications38

  1. ncbi request reprint Clinical pearls: factors affecting reported contraceptive efficacy rates in clinical studies
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Int J Fertil Womens Med 47:153-61. 2002
    ..Furthermore, clinical trial data may not accurately predict contraceptive efficacy in everyday use...
  2. ncbi request reprint Health economics of contraception
    R T Burkman
    Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Massachusetts, USA
    Obstet Gynecol Clin North Am 27:917-31, viii. 2000
    ..To date, there has been limited application of these methods to the area of contraception...
  3. ncbi request reprint The transdermal contraceptive system
    Ronald T Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S49-53. 2004
    ..Side effects are similar to those seen with OCs with the exception of application site reactions that are obviously unique to transdermal delivery...
  4. ncbi request reprint Current controversies: hormone replacement therapy and breast cancer
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Obstet Gynecol Surv 58:633-5. 2003
  5. ncbi request reprint Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study
    Ronald T Burkman
    National Cancer Institute Surveillance, Epidemiology, and End Results Registry, Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA
    Fertil Steril 79:844-51. 2003
    ..To determine the association between infertility drug use and invasive breast cancer in a population-based case-control study...
  6. ncbi request reprint Hormone replacement therapy. Current controversies
    R T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA, USA
    Minerva Ginecol 55:107-16. 2003
    ..The risk of colorectal cancer is decreased with use of hormone replacement therapy. In addition, the risk of osteopenia and osteoporosis is decreased as is the risk of osteoporotic fracture...
  7. ncbi request reprint Safety concerns and health benefits associated with oral contraception
    Ronald Burkman
    Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 190:S5-22. 2004
    ..Some of these benefits include reduction in menstrual-related symptoms, fewer ectopic pregnancies, a possible increase in bone density, and possible protection against pelvic inflammatory disease...
  8. ncbi request reprint Venous thromboembolism and oral contraceptives: current status and clinical implications
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
    Treat Endocrinol 1:143-7. 2002
    ....
  9. ncbi request reprint Reproductive hormones and cancer: ovarian and colon cancer
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Obstet Gynecol Clin North Am 29:527-40. 2002
    ..Available data are limited. Finally, there is growing evidence that hormone replacement therapy reduces risk of colorectal cancer, a benefit that accrues to perimenopausal women...
  10. doi request reprint Association between efficacy and body weight or body mass index for two low-dose oral contraceptives
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Contraception 79:424-7. 2009
    ..This analysis investigated the association of oral contraceptive efficacy with body weight and body mass index (BMI) for hypothesis-generating purposes...
  11. ncbi request reprint Transdermal hormonal contraception: benefits and risks
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    Am J Obstet Gynecol 197:134.e1-6. 2007
    ..Despite this, the contraceptive patch may be an appropriate option for some patients...
  12. ncbi request reprint Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
    J Reprod Med 52:1030-4. 2007
    ..To compare the effect of 2 oral contraceptives (OCs) on body weight...
  13. ncbi request reprint The transdermal contraceptive patch: a new approach to hormonal contraception
    Ronald T Burkman
    Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts, USA
    Int J Fertil Womens Med 47:69-76. 2002
    ..Partial or total detachment of the patch occurs at an overall rate of 3.8%. This rate is not affected by warm humid climates, vigorous exercise, or exposure to saunas or water baths...
  14. ncbi request reprint Hormone replacement therapy regimens and breast cancer risk(1)
    Linda K Weiss
    Population Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
    Obstet Gynecol 100:1148-58. 2002
    ..Progestin administered in an uninterrupted regimen may be a contributing factor. Risk dissipates once use is discontinued...
  15. ncbi request reprint Do thyroid disorders increase the risk of breast cancer?
    Michael S Simon
    Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
    Cancer Epidemiol Biomarkers Prev 11:1574-8. 2002
    ..There was no statistical interaction between thyroid disorders, thyroid treatments, and race, menopausal status, or parity. We found no association between thyroid disorders or their associated treatments and the risk of breast cancer...
  16. ncbi request reprint Racial differences in the familial aggregation of breast cancer and other female cancers
    Michael S Simon
    Division of Haematology and Oncology, Barbara Ann Karmanos Cancer Institute, 4100 John R, 4221 Hudson, Weber Cancer Research Building, Detroit, M1 48201, USA
    Breast Cancer Res Treat 89:227-35. 2005
    ..17 (1.22-3.85). In conclusion, these racially distinct aggregation patterns may reflect different modes of inheritance and/or environmental factors that impact cancer risk...
  17. ncbi request reprint Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study
    Michael S Simon
    Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, MI 48201, USA
    J Clin Oncol 24:2498-504. 2006
    ..The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women...
  18. ncbi request reprint Current perspectives on benefits and risks of hormone replacement therapy
    R T Burkman
    Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA USA
    Am J Obstet Gynecol 185:S13-23. 2001
    ..Overall, estrogen and hormone replacement therapy improves the quality of life and increases life expectancy for most menopausal women...
  19. doi request reprint Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, Florida, USA
    Obstet Gynecol 114:1205-12. 2009
    ..To compare bleeding patterns between a 21/7-day triphasic norgestimate/ethinyl estradiol (E2) 25-microgram oral contraceptive pill (OCP) and a 24/4-day drospirenone/ethinyl E2 20-microgram OCP...
  20. doi request reprint Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density
    Christine C Johnson
    Henry Ford Hospital, Detroit, MI 48202 3450, USA
    Contraception 77:239-48. 2008
    ..nonuse of the injectable (intramuscular) contraceptive depot medroxyprogesterone acetate (DMPA-IM) and its effect on bone mass in adolescent women...
  21. ncbi request reprint Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer
    Brian L Strom
    Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, 824 Blockley Hall, 423 Guardian Drive, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Contraception 69:353-60. 2004
    ..This study does not support an increased risk of breast cancer associated with the use of injectable or implantable progestin-only contraceptives in women aged 35 to 64...
  22. ncbi request reprint Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study
    Julia A Knight
    Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, ON, Canada, M5T 3L9
    Breast Cancer Res Treat 109:157-64. 2008
    ..Additional studies are required to determine the specific cyst type(s) responsible for the observed relationship...
  23. ncbi request reprint Risk of breast cancer associated with short-term use of oral contraceptives
    Suzanne G Folger
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Cancer Causes Control 18:189-98. 2007
    ..To estimate breast cancer risk associated with short-term (<6 months) oral contraceptive use, and explore variation in estimates by use characteristics and medical, menstrual, and reproductive history...
  24. ncbi request reprint The transdermal contraceptive patch: an updated review of the literature
    Katharine O'Connell
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Clin Obstet Gynecol 50:918-26. 2007
    ..Although concern has been raised about a possible increased risk of venous thromboembolism, current available data comparing the patch to a norgestimate-containing OC ranges from no increase in risk to a 2.4-fold increase...
  25. ncbi request reprint Reproductive hormones and cardiovascular disease mechanism of action and clinical implications
    Janice D Wagner
    Department of Pathology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1040, USA
    Obstet Gynecol Clin North Am 29:475-93. 2002
    ..The remainder of the study groups including an estrogen-only arm, are expected to continue until 2005...
  26. ncbi request reprint Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer
    Christopher I Li
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 15:946-54. 2006
    ....
  27. ncbi request reprint Lifetime recreational exercise activity and breast cancer risk among black women and white women
    Leslie Bernstein
    Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
    J Natl Cancer Inst 97:1671-9. 2005
    ....
  28. ncbi request reprint Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma
    Janet R Daling
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 95:2455-64. 2002
    ..However, the use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma...
  29. ncbi request reprint Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years
    Janet R Daling
    Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003
    ....
  30. ncbi request reprint Oral contraceptives and the risk of breast cancer
    Polly A Marchbanks
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 346:2025-32. 2002
    ..We conducted a population-based, case-control study to determine the risk of breast cancer among former and current users of oral contraceptives...
  31. ncbi request reprint The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results
    Polly A Marchbanks
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Ann Epidemiol 12:213-21. 2002
    ..This paper presents methods and operational results of a population-based case-control study examining the effects of oral contraceptive use on breast cancer risk among white and black women aged 35-64 years in five U.S. locations...
  32. ncbi request reprint Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Sandra A Norman
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Cancer Causes Control 14:933-43. 2003
    ..We examined breast cancer risk related to lifetime exposure to oral contraceptives (OCs) and hormone replacement therapy (HRT) in postmenopausal women...
  33. pmc Timing of menarche and first full-term birth in relation to breast cancer risk
    Christopher I Li
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 167:230-9. 2008
    ..The authors conclude that the interval between age at menarche and age at first birth is associated with the risk of hormonally sensitive types of breast cancer, particularly among White women...
  34. ncbi request reprint Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
    Kathleen E Malone
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Res 66:8297-308. 2006
    ....
  35. ncbi request reprint Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch
    Frank A Sonnenberg
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA
    Am J Obstet Gynecol 192:1-9. 2005
    ..The purpose of this study was to examine implications of increased perfect use on the cost-effectiveness of the contraceptive patch compared with combination oral contraceptives (COCs)...
  36. ncbi request reprint Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study
    Jill A McDonald
    National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, 4770 Buford Highway Northeast, MS K22, Atlanta, GA 30341 3724, USA
    Cancer Epidemiol Biomarkers Prev 13:2106-16. 2004
    ..To explore associated biological outcomes and clarify the role of timing of exposure in the alcohol-breast cancer relationship...
  37. ncbi request reprint Reproductive factors and risk of breast carcinoma in a study of white and African-American women
    Giske Ursin
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
    Cancer 101:353-62. 2004
    ....
  38. ncbi request reprint Costs and net health effects of contraceptive methods
    Frank A Sonnenberg
    Division of General Internal Medicine, UMDNJ Robert Wood Johnson Medical School, 125 Paterson Street, Room 2302, New Brunswick, NJ 08903 USA
    Contraception 69:447-59. 2004
    ..Pregnancy and contraceptive methods both have important health effects that include risks and benefits. The net impact of contraception on women's health has not been reported previously...